login
login
Image header Agence Europe
Europe Daily Bulletin No. 13402
Contents Publication in full By article 32 / 37
NEWS BRIEFS / Lobbying

Ursula von der Leyen justifies European Commission’s approach to negotiations on Covid-19 vaccines

30/04/2024 (Agence Europe)On Monday 29 April, the President of the European Commission, Ursula von der Leyen, justified the steps taken by the European Union institution in connection with the joint purchase of vaccines against Covid-19 at a time when she is being criticised for her lack of transparency in her dealings with the CEO of the pharmaceutical giant Pfizer (see EUROPE 13161/30). “We’ve achieved to vaccinate 80% of the Europeans at least with one shot. (of vaccine). How were contracts made? They were approved by the Member States. Each individual Member State had a contract with a pharmaceutical company. They were signed by the Member states and not by European Commission. The money that flew was Member States’ money, not EU money”, she declared during a debate in Maastricht between the candidates heading the European party lists for the European elections in June. (MB)

Contents

SECTORAL POLICIES
EXTERNAL ACTION
INSTITUTIONAL
SECURITY - DEFENCE
SOCIAL AFFAIRS - EMPLOYMENT
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
NEWS BRIEFS